vs
Side-by-side financial comparison of Elanco Animal Health Inc (ELAN) and LOGITECH INTERNATIONAL S.A. (LOGI). Click either name above to swap in a different company.
LOGITECH INTERNATIONAL S.A. is the larger business by last-quarter revenue ($1.4B vs $1.1B, roughly 1.2× Elanco Animal Health Inc). LOGITECH INTERNATIONAL S.A. runs the higher net margin — 17.7% vs -24.1%, a 41.8% gap on every dollar of revenue. On growth, Elanco Animal Health Inc posted the faster year-over-year revenue change (12.2% vs 6.1%). LOGITECH INTERNATIONAL S.A. produced more free cash flow last quarter ($465.6M vs $46.0M). Over the past eight quarters, LOGITECH INTERNATIONAL S.A.'s revenue compounded faster (18.5% CAGR vs -2.6%).
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.
Logitech International S.A. is a Swiss multinational manufacturer of computer peripherals and software. Headquartered in Lausanne, Switzerland, the company has offices throughout Europe, Asia, Oceania, and the Americas. It is a component of the Swiss Market Index, and is listed on the Nasdaq.
ELAN vs LOGI — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.4B |
| Net Profit | $-276.0M | $251.0M |
| Gross Margin | 51.5% | 43.2% |
| Operating Margin | -22.6% | 20.1% |
| Net Margin | -24.1% | 17.7% |
| Revenue YoY | 12.2% | 6.1% |
| Net Profit YoY | -3350.0% | 25.4% |
| EPS (diluted) | $-0.55 | $1.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.2B | $1.0B | ||
| Q4 24 | $1.0B | $1.3B | ||
| Q3 24 | $1.0B | $1.1B | ||
| Q2 24 | $1.2B | $1.1B | ||
| Q1 24 | $1.2B | $1.0B |
| Q4 25 | $-276.0M | $251.0M | ||
| Q3 25 | $-34.0M | $170.7M | ||
| Q2 25 | $11.0M | $146.0M | ||
| Q1 25 | $67.0M | $144.1M | ||
| Q4 24 | $-8.0M | $200.1M | ||
| Q3 24 | $364.0M | $145.5M | ||
| Q2 24 | $-50.0M | $141.8M | ||
| Q1 24 | $32.0M | $167.6M |
| Q4 25 | 51.5% | 43.2% | ||
| Q3 25 | 53.4% | 43.4% | ||
| Q2 25 | 57.5% | 41.7% | ||
| Q1 25 | 57.3% | 43.1% | ||
| Q4 24 | 50.9% | 42.9% | ||
| Q3 24 | 52.2% | 43.6% | ||
| Q2 24 | 58.2% | 42.8% | ||
| Q1 24 | 57.3% | 43.2% |
| Q4 25 | -22.6% | 20.1% | ||
| Q3 25 | -4.4% | 16.1% | ||
| Q2 25 | 2.0% | 14.1% | ||
| Q1 25 | 5.0% | 10.5% | ||
| Q4 24 | -5.0% | 17.5% | ||
| Q3 24 | 54.3% | 14.4% | ||
| Q2 24 | -2.7% | 14.1% | ||
| Q1 24 | 1.0% | 12.9% |
| Q4 25 | -24.1% | 17.7% | ||
| Q3 25 | -3.0% | 14.4% | ||
| Q2 25 | 0.9% | 12.7% | ||
| Q1 25 | 5.6% | 14.3% | ||
| Q4 24 | -0.8% | 14.9% | ||
| Q3 24 | 35.3% | 13.0% | ||
| Q2 24 | -4.2% | 13.0% | ||
| Q1 24 | 2.7% | 16.6% |
| Q4 25 | $-0.55 | $1.69 | ||
| Q3 25 | $-0.07 | $1.15 | ||
| Q2 25 | $0.02 | $0.98 | ||
| Q1 25 | $0.13 | $0.94 | ||
| Q4 24 | $-0.01 | $1.32 | ||
| Q3 24 | $0.73 | $0.95 | ||
| Q2 24 | $-0.10 | $0.92 | ||
| Q1 24 | $0.06 | $1.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $545.0M | $1.8B |
| Total DebtLower is stronger | $3.9B | — |
| Stockholders' EquityBook value | $6.5B | $2.3B |
| Total Assets | $13.4B | $4.1B |
| Debt / EquityLower = less leverage | 0.60× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $545.0M | $1.8B | ||
| Q3 25 | $505.0M | $1.4B | ||
| Q2 25 | $539.0M | $1.5B | ||
| Q1 25 | $487.0M | $1.5B | ||
| Q4 24 | $468.0M | $1.5B | ||
| Q3 24 | $490.0M | $1.4B | ||
| Q2 24 | $416.0M | $1.5B | ||
| Q1 24 | $345.0M | $1.5B |
| Q4 25 | $3.9B | — | ||
| Q3 25 | $4.0B | — | ||
| Q2 25 | $4.1B | — | ||
| Q1 25 | $4.4B | — | ||
| Q4 24 | $4.3B | — | ||
| Q3 24 | $4.4B | — | ||
| Q2 24 | $5.7B | — | ||
| Q1 24 | $5.8B | — |
| Q4 25 | $6.5B | $2.3B | ||
| Q3 25 | $6.7B | $2.1B | ||
| Q2 25 | $6.8B | $2.2B | ||
| Q1 25 | $6.4B | $2.1B | ||
| Q4 24 | $6.1B | $2.1B | ||
| Q3 24 | $6.5B | $2.1B | ||
| Q2 24 | $5.9B | $2.2B | ||
| Q1 24 | $6.1B | $2.2B |
| Q4 25 | $13.4B | $4.1B | ||
| Q3 25 | $13.6B | $3.7B | ||
| Q2 25 | $13.7B | $3.7B | ||
| Q1 25 | $12.9B | $3.5B | ||
| Q4 24 | $12.6B | $3.7B | ||
| Q3 24 | $13.3B | $3.6B | ||
| Q2 24 | $13.8B | $3.7B | ||
| Q1 24 | $14.0B | $3.6B |
| Q4 25 | 0.60× | — | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.69× | — | ||
| Q4 24 | 0.70× | — | ||
| Q3 24 | 0.67× | — | ||
| Q2 24 | 0.96× | — | ||
| Q1 24 | 0.95× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $108.0M | $480.5M |
| Free Cash FlowOCF − Capex | $46.0M | $465.6M |
| FCF MarginFCF / Revenue | 4.0% | 32.8% |
| Capex IntensityCapex / Revenue | 5.4% | 1.0% |
| Cash ConversionOCF / Net Profit | — | 1.91× |
| TTM Free Cash FlowTrailing 4 quarters | $284.0M | $903.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.0M | $480.5M | ||
| Q3 25 | $219.0M | $228.8M | ||
| Q2 25 | $237.0M | $125.0M | ||
| Q1 25 | $-4.0M | $129.7M | ||
| Q4 24 | $177.0M | $370.9M | ||
| Q3 24 | $162.0M | $166.0M | ||
| Q2 24 | $200.0M | $176.0M | ||
| Q1 24 | $2.0M | $239.1M |
| Q4 25 | $46.0M | $465.6M | ||
| Q3 25 | $127.0M | $212.3M | ||
| Q2 25 | $180.0M | $108.8M | ||
| Q1 25 | $-69.0M | $116.9M | ||
| Q4 24 | $130.0M | $356.6M | ||
| Q3 24 | $120.0M | $151.5M | ||
| Q2 24 | $166.0M | $161.4M | ||
| Q1 24 | $-22.0M | $228.8M |
| Q4 25 | 4.0% | 32.8% | ||
| Q3 25 | 11.2% | 17.9% | ||
| Q2 25 | 14.5% | 9.5% | ||
| Q1 25 | -5.8% | 11.6% | ||
| Q4 24 | 12.7% | 26.6% | ||
| Q3 24 | 11.7% | 13.6% | ||
| Q2 24 | 14.0% | 14.8% | ||
| Q1 24 | -1.8% | 22.6% |
| Q4 25 | 5.4% | 1.0% | ||
| Q3 25 | 8.1% | 1.4% | ||
| Q2 25 | 4.6% | 1.4% | ||
| Q1 25 | 5.4% | 1.3% | ||
| Q4 24 | 4.6% | 1.1% | ||
| Q3 24 | 4.1% | 1.3% | ||
| Q2 24 | 2.9% | 1.3% | ||
| Q1 24 | 2.0% | 1.0% |
| Q4 25 | — | 1.91× | ||
| Q3 25 | — | 1.34× | ||
| Q2 25 | 21.55× | 0.86× | ||
| Q1 25 | -0.06× | 0.90× | ||
| Q4 24 | — | 1.85× | ||
| Q3 24 | 0.45× | 1.14× | ||
| Q2 24 | — | 1.24× | ||
| Q1 24 | 0.06× | 1.43× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELAN
| Pet Health | $489.0M | 43% |
| Cattle | $296.0M | 26% |
| Poultry | $237.0M | 21% |
| Swine | $107.0M | 9% |
| Contract Manufacturing | $15.0M | 1% |
LOGI
| Retail Gaming | $482.7M | 34% |
| Retail Keyboards Desktops | $254.6M | 18% |
| Retail Pointing Devices | $241.2M | 17% |
| Retail Video Collaboration | $193.3M | 14% |
| Retail Tablet And Other Accessories | $93.6M | 7% |
| Retail Webcams | $82.3M | 6% |
| Retail Headsets | $45.9M | 3% |
| Other Retail Products | $28.0M | 2% |
